Related Experiment Video

Updated: May 3, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

20.8K

Cancer-testis genes as candidates for immunotherapy in breast cancer

Soudeh Ghafouri-Fard1, Roshanak Shamsi, Mahnaz Seifi-Alan

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran.

Immunotherapy
|February 5, 2014
PubMed

Insights

Cancer-testis (CT) antigens show promise for cancer immunotherapy and prevention. Research highlights their expression in breast cancers, supporting the development of new cancer vaccines.

Area of Science:

  • Immunology
  • Oncology

Background:

  • Cancer-testis (CT) antigens are tumor-associated antigens with potential applications in cancer immunotherapy.
  • Clinical trials have explored the therapeutic efficacy of CT antigens in cancer patients.
  • Significant CT gene expression is observed in breast cancers, particularly triple-negative subtypes.

Purpose of the Study:

  • To identify highly expressed CT genes in cancer patients for immunotherapeutic strategies.
  • To explore the potential of CT genes in both cancer immunotherapy and immunoprevention for high-risk individuals.
  • To investigate the immunogenicity of CT genes in breast cancer patients for vaccine development.

Main Methods:

  • Analysis of CT gene expression in cancer patients.
  • Review of clinical trial data on CT antigen-based therapies.
  • Assessment of CT gene immunogenicity in breast cancer patients.

Main Results:

  • CT genes are crucial targets for cancer immunotherapy.
  • High expression of CT genes is noted in breast and triple-negative cancers.
  • Many CT genes are immunogenic in breast cancer patients, indicating vaccine potential.

Conclusions:

  • CT antigens are promising targets for cancer immunotherapy and immunoprevention.
  • Identifying highly expressed CT genes is essential for developing effective cancer treatments.
  • The immunogenicity of CT genes supports the creation of polyvalent cancer vaccines.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K